Northwire Canada EditionSunday, October 18, 2026
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%
Production / Operations

Telescope Innovations Plans Expansion of DirectInject-LC(TM) Technology Ecosystem to Fuel the Physical AI Revolution

TELI · Price

Executive Summary

  • Telescope Innovations announced its 2026 technology development pipeline, adding two new analytical platforms—DirectInject‑IC™ (Ion Chromatography) and DirectInject‑ICP™ (Inductively Coupled Plasma)—to complement its existing DirectInject‑LC™ system.
  • The new platforms are intended to enable real‑time, autonomous monitoring for industrial applications such as hydrometallurgy, lithium extraction, and energy/battery material processing.
  • Deployment and testing of the DirectInject‑IC™ and DirectInject‑ICP™ versions are targeted for the second half of 2026, expanding Telescope’s addressable market in minerals and inorganic chemistry sectors.

Key Details

  • DirectInject‑IC™ – integrates ion chromatography with the DirectInject platform to provide quantitative analysis of inorganic species; aimed at process monitoring and feedback control in hydrometallurgy, lithium extraction, etc.
  • DirectInject‑ICP™ – couples inductively coupled plasma spectroscopy with DirectInject for elemental analysis; positioned for energy & battery material applications requiring trace metal detection.
  • Both platforms are part of Telescope’s “Sensor Suite” expansion to support autonomous decision‑making in Self‑Driving Labs (SDLs).
  • Expected timeline: early‑adopter deployment and testing slated for H2 2026.
  • CEO Henry Dubina emphasized that the expansions build on the commercial success of DirectInject‑LC™ and aim to capture additional industrial segments related to minerals and inorganic chemistry.

Notable Quotes

“Telescope is not resting on the success of DirectInject‑LC; we are building on that momentum to provide the full analytical ‘eyes’ required for the automation age.” – Henry Dubina, CEO


Materiality Assessment: Non‑Material – Positive (forward‑looking product roadmap with no immediate financial impact).

Read the original news release →

More from Telescope Innovations Corp.